Shakeup at BenevolentAI continues with job, programme cuts
BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third
FDA clears ImmunityBio’s bladder cancer drug at 2nd attempt
After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product.
How do we unlock the potential of digital health?
‘Digital health’ has been heralded for some time as a new era in patient outcomes, offering increased access to care, enhanced clinical decision-making, and greater efficiency in healthcare
EU approves Pfizer antibiotic for superbug infections
Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections.
BMS preps for CAR-T growth with $380m Cellares deal
Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies, tapping into capacity at contract manufacturer Cellares that will be used to supply patients in th
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
FT US PHARMA AND BIOTECH SUMMIT
2024 is a pivotal year for the US healthcare sector.
The PM Society – Giving Back
The PM Society is a not-for-profit organisation with 40 years of Giving Back.
5th Optimizing Hybrid Clinical Trials Summit
The 5th Optimizing Hybrid Clinical Trials Summit (September 11-12, 2024 | Boston, MA) is uniting stakeholders in Clinical Operations, Innovation, Procurement and Digital Health and
2nd RNA Assay Development Screening Summit
This August, the 2nd RNA Assay Development & Screening Summit returns to Boston as the first and only industry dedicated event on developing sensitive, and reproducible assay and screening meth
3rd HF Drug Discovery & Development Summit
The Industry’s Only Definitive Forum for Preclinical Heart Failure Drug Development